Precision Medicine Meets Precision Patient Support

In the value-driven healthcare environment, orphan drug manufacturers are becoming increasingly aware that improving adherence requires a new approach to patient understanding and support. Take for example the required lifestyle, nutritional or physical modifications often necessary for patient compliance — behaviors that are difficult to influence, track or control without proper patient insights and ongoing therapy support services.

In this white paper, Kathi Henson discusses how unmet patient needs and insights inform a new model for orphan drug therapy support services.